India’s Alembic Pharma Q2 profit roughly in-line with estimates
BENGALURU (Reuters) – India’s Alembic Pharmaceuticals on Tuesday reported second-quarter profit roughly in line with estimates, as higher sales in its domestic and overseas markets offset a jump in expenses. The generic drugmaker’s consolidated net profit came in at 1.37 billion rupees ($16.5 million) for the quarter ended Sept. 30, up 3% from last year. …
India’s Alembic Pharma Q2 profit roughly in-line with estimates Read More »






